| Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? JE Maxwell, SK Sherman, TM O'Dorisio, AM Bellizzi, JR Howe Surgery 159 (1), 320-335, 2016 | 178 | 2016 |
| The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms Annals of surgical oncology 27 (6), 1753-1760, 2020 | 109* | 2020 |
| Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors SK Sherman, JC Carr, D Wang, MS O’Dorisio, TM O’Dorisio, JR Howe Surgery 154 (6), 1206-1214, 2013 | 74 | 2013 |
| Pancreastatin predicts survival in neuroendocrine tumors SK Sherman, JE Maxwell, MS O’Dorisio, TM O’Dorisio, JR Howe Annals of surgical oncology 21, 2971-2980, 2014 | 66 | 2014 |
| Medical management of metastatic medullary thyroid cancer JE Maxwell, SK Sherman, TM O'Dorisio, JR Howe Cancer 120 (21), 3287-3301, 2014 | 52 | 2014 |
| A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors JE Maxwell, SK Sherman, KM Stashek, TM O'Dorisio, AM Bellizzi, ... Surgery 156 (6), 1359-1366, 2014 | 49 | 2014 |
| The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma Annals of surgical oncology 27 (6), 1774-1779, 2020 | 48 | 2020 |
| Cost-effectiveness of maintenance capecitabine and bevacizumab for metastatic colorectal cancer SK Sherman, JJ Lange, FS Dahdaleh, R Rajeev, TC Gamblin, BN Polite, ... JAMA oncology 5 (2), 236-242, 2019 | 47 | 2019 |
| The Chicago consensus on peritoneal surface malignancies: management of colorectal metastases Annals of surgical oncology 27 (6), 1761-1767, 2020 | 46 | 2020 |
| The Chicago consensus on peritoneal surface malignancies: management of gastric metastases Annals of surgical oncology 27 (6), 1768-1773, 2020 | 38 | 2020 |
| Effect of BMI on outcomes in proctectomy JE Hrabe, SK Sherman, ME Charlton, JW Cromwell, JC Byrn Diseases of the colon & rectum 57 (5), 608-615, 2014 | 37 | 2014 |
| RABL6A Promotes G1–S Phase Progression and Pancreatic Neuroendocrine Tumor Cell Proliferation in an Rb1-Dependent Manner J Hagen, VP Muniz, KC Falls, SM Reed, AF Taghiyev, FW Quelle, ... Cancer research 74 (22), 6661-6670, 2014 | 36 | 2014 |
| Limitations of somatostatin scintigraphy in primary small bowel neuroendocrine tumors JE Maxwell, SK Sherman, Y Menda, D Wang, TM O'Dorisio, JR Howe Journal of surgical research 190 (2), 548-553, 2014 | 34 | 2014 |
| The Chicago Consensus on peritoneal surface malignancies: management of ovarian neoplasms Annals of surgical oncology 27 (6), 1780-1787, 2020 | 32* | 2020 |
| Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors JE Maxwell, SK Sherman, G Li, AB Choi, AM Bellizzi, TM O'Dorisio, ... Cancer genetics 208 (11), 564-570, 2015 | 29 | 2015 |
| Surgical management of neuroendocrine tumor liver metastases CG Tran, SK Sherman, C Chandrasekharan, JR Howe Surgical Oncology Clinics 30 (1), 39-55, 2021 | 28 | 2021 |
| Translational diagnostics and therapeutics in pancreatic neuroendocrine tumors JE Maxwell, SK Sherman, JR Howe Clinical cancer research 22 (20), 5022-5029, 2016 | 28 | 2016 |
| Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors SK Sherman, JE Maxwell, JC Carr, D Wang, AM Bellizzi, M Sue O’Dorisio, ... Clinical & experimental metastasis 31, 935-944, 2014 | 28 | 2014 |
| Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors JC Carr, SK Sherman, D Wang, FS Dahdaleh, AM Bellizzi, MS O’Dorisio, ... Annals of surgical oncology 20, 739-746, 2013 | 28 | 2013 |
| The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors Annals of surgical oncology 27 (6), 1788-1792, 2020 | 27 | 2020 |
Fadi Dahdalehuniversity of ChicagoVerified email at uchospitals.edu
